Top

LATEST PUBLICATIONS



Clinical Trial Management System Market: Software is anticipated to be Most Lucrative Segment

March 30, 2021

According to Transparency Market Research’s latest report on the global clinical trials management system (CTMS)market for the historical period 2017–2018 and forecast period 2019–2027, rising demand for new therapies and increasing research and developmental activities to drive the global clinical […]


Biotechs Bolstering Bank Accounts by Selling Stock This Week

March 25, 2021

Category: Biotech, Industry

Several new initial public offering (IPO) announcements have been made by international and U.S.-based biopharmaceutical and biotechnology companies in the past couple of days, with Dutch biotechnology company LAVA Therapeutics leading the pact. LAVA, a company harnessing expertise in bispecific […]


Novel cancer-fighting gene therapy enters phase I clinical trial

March 18, 2021

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells. The safety of the novel therapy is now being tested on […]


Industry, News, Vaccines

Biden moves deadline for states to open Covid vaccines to all U.S. adults to April 19

April 6, 2021

Via: CNBC

President Joe Biden announced Tuesday that states should open Covid-19 vaccine appointments to all U.S. adults by April 19, moving up his original deadline by nearly two weeks. Biden announced the new deadline after he visited a vaccination site in […]


Biotech, Cell and Gene Therapy, Industry

HitGen and BioAge Announce Research Progress in DNA-Encoded Library Based Drug Discovery Research Collaboration

April 6, 2021

Via: BioSpace

Shanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a collaboration with BioAge Labs, Inc. (“BioAge”), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging. The companies have conducted […]


Biotech, Industry, Manufacturing, News, Research and Development, Vaccines

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments

April 5, 2021

Via: BioSpace

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]


Biotech, FDA, Industry, Regulations

FDA Provides Positive Feedback on Tetra Bio-Pharma’s Application for ARDS-003 Clinical Development in COVID-19 Patients

April 5, 2021

Via: BioSpace

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development is pleased to announce that the U.S. Food and Drug Administration (FDA) has favorably reviewed the preclinical data package and clinical development plan […]


Industry, News, Vaccines

COVID-19 Vaccine Market: Nucleic acid vaccines segment to dominate global market

April 2, 2021

Via: BioSpace

COVID-19 is a pneumonic disease that is caused by SARS-Cov2 virus. Previous ancestors of COVID-19 virus are SARS-CoV and MERS Virus. Loss of few base pairs has led to the mutation in the genetic material of SARS-CoV2. High multiplication rate […]


Clinical Trials, News, Research and Development

Study identifies possible COVID-19 drugs — including several that are FDA-approved

April 2, 2021

Via: ScienceDaily

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. […]